Stem cell transplant and Intestinal obstruction
Summary:
Intestinal obstruction is found among people with Stem cell transplant, especially for people who are male, 30-39 old.
The study analyzes which people have Intestinal obstruction with Stem cell transplant. It is created by eHealthMe based on reports of 38 people who have Stem cell transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Stem cell transplant?
Stem cell transplant is found to be associated with 430 drugs and 386 conditions by eHealthMe. Check the latest studies of Stem cell transplant.
What is Intestinal obstruction?
Intestinal obstruction is found to be associated with 1,885 drugs and 2,617 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.
38 people who have Stem Cell Transplant and Intestinal Obstruction are studied.

Gender of people who have Stem Cell Transplant and experienced Intestinal Obstruction *:
- female: 50 %
- male: 50 %
Age of people who have Stem Cell Transplant and experienced Intestinal Obstruction *:
- 0-1: 0.0 %
- 2-9: 27.78 %
- 10-19: 2.7800000000000002 %
- 20-29: 8.33 %
- 30-39: 30.56 %
- 40-49: 2.7800000000000002 %
- 50-59: 8.33 %
- 60+: 19.44 %
Common co-existing conditions for these people *:
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 21.05%
- Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 4 people, 10.53%
- Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 5.26%
- Immunodeficiency Disorders: 2 people, 5.26%
- Bone Marrow Conditioning Regimen: 1 person, 2.63%
- Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 2.63%
Common drugs taken by these people *:
- Cyclosporine: 16 people, 42.11%
- Cyclophosphamide: 15 people, 39.47%
- Busulfex: 12 people, 31.58%
- Busulfan: 11 people, 28.95%
- Mycophenolate Mofetil: 11 people, 28.95%
- Neupogen: 10 people, 26.32%
- Cytarabine: 9 people, 23.68%
- Melphalan: 7 people, 18.42%
- Methotrexate: 7 people, 18.42%
- Fludarabine Phosphate: 6 people, 15.79%
Common symptoms for these people *:
- Nausea (feeling of having an urge to vomit): 11 people, 28.95%
- Fever: 11 people, 28.95%
- Nausea And Vomiting: 9 people, 23.68%
- Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 9 people, 23.68%
- Loss Of Consciousness: 9 people, 23.68%
- Sepsis (a severe blood infection that can lead to organ failure and death): 8 people, 21.05%
- Acute Kidney Failure: 8 people, 21.05%
- Hepatitis (inflammation of the liver): 8 people, 21.05%
- Abdominal Pain: 7 people, 18.42%
- Acute Graft Versus Host Disease In Intestine (acute complication in intestine following an allogeneic tissue/blood transplant): 7 people, 18.42%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Intestinal obstruction?
- Check whether Intestinal obstruction is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Stem cell transplant (13,935 reports)
- Intestinal obstruction (59,346 reports)
All the drugs that are associated with Intestinal obstruction:
- Intestinal obstruction (1,885 drugs)
All the conditions that are associated with Intestinal obstruction:
- Intestinal obstruction (2,617 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Intestinal obstruction and Stem cell transplant, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Smell - Impaired in Gralise, how severe and when it was recovered? - 13 seconds ago
- Hydrochlorothiazide and Chills for Women aged 60+ - 15 seconds ago
- Hydrochlorothiazide and Rigors for Women aged 60+ - 15 seconds ago
- Hydrochlorothiazide and Shivering for Women aged 60+ - 15 seconds ago
- Could Cytomel cause Paranoia Aggravated? - 43 seconds ago
- Brilinta and Hair Loss for Women aged 60+ - 52 seconds ago
- Brilinta and Hair Thinning for Women aged 60+ - 53 seconds ago
- Brilinta and Loss Of Hair for Women aged 60+ - 53 seconds ago
- Brilinta and Hairloss for Women aged 60+ - 53 seconds ago
- Brilinta and Baldness for Women aged 60+ - 53 seconds ago